Biopsy Devices Market Size, Share, and Forecast by 2031
Biopsy Devices Market: Size and Share
-
CAGR (2023 - 2031)6.20% -
Market Size 2023
US$ 2.83 Billion -
Market Size 2031
US$ 4.59 Billion
Market Dynamics
- Growing prevalence of cancer worldwide
- Growing cancer-related Spending
- Rapid advancements in oncology, new product launches, and a strong pipeline of biopsy devices
Market Segmentation
Product - Needle-Based Biopsy
- Localization Wires
- Procedure Trays
Technology - CT Scan
- Ultrasound-Guided Biopsy
- Stereotactic-Guided Biopsy
- MRI-Guided Biopsy
Application - Lung Biopsy
- Kidney Biopsy
- Liver Biopsy
- Breast Biopsy
Biopsy Devices Market Players Density: Understanding Its Impact on Business Dynamics
The Biopsy Devices Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Biopsy Devices Market are:
- BD
- QIAGEN
- Hologic
- Bio-Rad Laboratories
- Cardinal Health
- Medtronic plc
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Biopsy Devices Market top key players overview
Get Free Sample For